Open AccessAtorvastatin administration is associated with dose-related changes in IGF bioavailability
Author(s) -
Ram Prakash Narayanan,
Matthew Gittins,
Kirk Siddals,
Robert L. Oliver,
J Hudson,
Anne White,
Paul N. Durrington,
Robert R. Davies,
Martin K. Rutter,
Martin Gibson
Publication year - 2013
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje-12-0844
Subject(s) - atorvastatin , igfbp3 , bioavailability , medicine , endocrinology , statin , type 2 diabetes , diabetes mellitus , pharmacology , growth factor , receptor
IGF levels, their binding proteins (IGFBPs) and high-dose statin therapy have been linked to the development of diabetes. We aimed to identify whether atorvastatin caused dose-related changes in IGF proteins.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom